BVT Bonus Zert FRE 31.12.2024/ DE000VC2T3W1 /
11.12.2024 10:34:42 | Изменение+0.130 | Бид10:46:54 | Предложение10:46:54 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
35.970EUR | +0.36% | - Величина цены спроса: - |
- Величина цены предложения: - |
FRESENIUS SE+CO.KGAA... | - - | 31.12.2024 | Call |
GlobeNewswire
24.04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23.04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23.02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04.09.2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31.08.2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница